This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jens Assmann: Innovator in Pharmaceutical Chemistry
Introduction
Jens Assmann is a notable inventor based in Haan, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods in drug preparation. His work is characterized by a focus on electrochemical methods for synthesizing complex compounds.
Latest Patents
Jens Assmann holds a patent for a method titled "Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and recovery of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide by electrochemical methods." This invention relates to a novel process for preparing a specific compound and recovering it through innovative techniques.
Career Highlights
Jens Assmann is associated with Bayer Pharma Aktiengesellschaft, a leading company in the pharmaceutical industry. His work at Bayer has allowed him to explore and develop new methodologies that enhance drug preparation processes. He has been recognized for his contributions to the field, particularly in the area of electrochemical synthesis.
Collaborations
Throughout his career, Jens has collaborated with esteemed colleagues, including Johannes Platzek and Kathrin Gottfried. These collaborations have fostered an environment of innovation and have led to advancements in pharmaceutical research.
Conclusion
Jens Assmann's contributions to pharmaceutical chemistry through his innovative patent and collaborations highlight his role as a significant inventor in the field. His work continues to influence drug preparation methodologies and showcases the importance of innovation in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
